I'm a PhD candidate in the Department of Public Health and Primary Care at the University of Cambridge under the supervision of Professor Carol Brayne and Dr. Andres Roman-Urrestarazu. My doctoral research focused on elucidating the social and economic epidemiology of substance-related disorders and related health disparities by examining administrative and routinely collected datasets, including admissions data and nationally representative surveys. I passed my viva voce examination in June 2019 and have been approved for my degree as of September 2019. Before starting my PhD, I worked as a Senior Associate at Avalere Health where my work focused on market access and product commercialisation for life science sector clients.
My areas of broad academic interest include: psychiatric epidemiology, urban health policy, and health services research. In addition, I am interested in interdisciplinary approaches to social problems which may benefit from a public health lens, including criminal justice reform and social care policy. In my spare time, I enjoy travelling, tabletop gaming, and literary fiction.
- PhD in Public Health and Primary Care, University of Cambridge (2015-19)
- MSPH in Health Policy, Johns Hopkins University (2013-15)
- Certificate in Health Finance and Management (2013-15)
- Certificate in Public Health Informatics (2013-15)
- PGDip in Commerce (General Management), Thompson Rivers University (2012-13)
- BSc in Biology (Cell Biology and Genetics option), University of British Columbia (2007-12)
- BA (Hons) in English, University of British Columbia (2007-12)
Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS one. 2019; 14(8):e0221153.
Yang JC, Roman-Urrestarazu A, McKee M, Brayne C. Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002-16. IJEH. 2019;18(1):122.
Neicun J, Steenhuizen M, van Kessel R, Yang JC, Negri A, Czabanowska K, Corazza O, Roman-Urrestarazu A. Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom, and Sweden. PloS one. 2019;14(6): e0218011.
Roman-Urrestarazu A, Yang JC, Robertson R, McCallum A, Gray C, McKee M, Middleton J. Brexit threatens the UK’s ability to tackle illicit drugs and organised crime: what needs to happen now?. Health Policy. 2019;123(6):521.
Prilutskaya M, Yang JC, Roman-Urrestarazu A. Synthetic Cannabinoids, Opioids, and Polydrug Use: Clinical Implications. In: (Eds) Corazza, O, Roman-Urrestarazu, A. Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS. Routledge; 2018.
Roman-Urrestarazu A, Yang JC, Ettelt S, Thalmann I, Seguel Ravest V, Brayne C. Private health insurance in Germany and Chile: two stories of co-existence, segmentation and conflict. IJEH. 2018;17(1):112.
Yang JC, Roman-Urrestarazu A, Brayne C. Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States. PloS one. 2018;13(6):e0199741.
Yang JC, Roman-Urrestarazu A. "Self-reported use of novel psychoactive substances (NPS) in the United States from 2007-14: trends in prevalence and user characteristics from the national surveys on drug use and health." Fifth international conference on novel psychoactive substances. 2017.